Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

LARS anticorps (AA 250-300)

LARS Reactivité: Humain, Souris WB, IHC (fp) Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7454577
  • Antigène Voir toutes LARS Anticorps
    LARS (Leucyl-tRNA Synthetase (LARS))
    Épitope
    • 4
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    AA 250-300
    Reactivité
    • 18
    • 8
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain, Souris
    Hôte
    • 20
    Lapin
    Clonalité
    • 20
    Polyclonal
    Conjugué
    • 17
    • 1
    • 1
    • 1
    Cet anticorp LARS est non-conjugé
    Application
    • 17
    • 6
    • 5
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections) (IHC (fp))
    Fonction
    Rabbit anti-LARS Antibody, Affinity Purified
    Homologie
    Orangutan
    Purification
    Affinity Purified
    Immunogène
    Between AA 250 and 300
    Isotype
    IgG
    Top Product
    Discover our top product LARS Anticorps primaire
  • Indications d'application

    IHC: 1:500 - 1:2,000. Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections.

    IP: Not recommended

    WB: 1:1,000 - 1:5,000

    Restrictions
    For Research Use only
  • Concentration
    1000 μg/mL
    Buffer
    Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C
    Date de péremption
    12 months
  • Antigène
    LARS (Leucyl-tRNA Synthetase (LARS))
    Autre désignation
    LARS (LARS Produits)
    Synonymes
    anticorps HSPC192, anticorps LARS1, anticorps LEURS, anticorps LEUS, anticorps LRS, anticorps PIG44, anticorps RNTLS, anticorps hr025Cl, anticorps CG7479, anticorps Dmel\\CG7479, anticorps LeuRS, anticorps F21M12.1, anticorps F21M12_1, anticorps BA4991, anticorps DDBDRAFT_0183834, anticorps DDBDRAFT_0231251, anticorps DDB_0183834, anticorps DDB_0231251, anticorps 2310045K21Rik, anticorps 3110009L02Rik, anticorps AW536573, anticorps mKIAA1352, anticorps leucyl-tRNA synthetase, anticorps Leucyl-tRNA synthetase, mitochondrial, anticorps ATP binding/leucine-tRNA ligases/aminoacyl-tRNA ligase, anticorps leucine--tRNA ligase, anticorps leucyl-tRNA synthetase LeuS, anticorps leucyl-tRNA ligase, anticorps leucine-tRNA ligase, anticorps LARS, anticorps LeuRS-m, anticorps AT1G09620, anticorps leuS, anticorps APH_RS02290, anticorps mleuS, anticorps Lars
    Sujet
    Background: Leucyl-tRNA synthetase (LARS) catalyzes the specific attachment of an amino acid to its cognate tRNA in a two step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. LARS exhibits a post-transfer editing activity to hydrolyze mischarged tRNAs [taken from the Universal Protein Resource (UniProt) Q9P2J5].
    ID gène
    51520
    NCBI Accession
    NP_064502
    UniProt
    Q9P2J5
    Pathways
    EGFR Signaling Pathway
Vous êtes ici:
Support technique